News Archive - School of Medicine

Wearable Ultrasound Patch Monitors Blood Pressure Deep Inside Body

A new wearable ultrasound patch that non-invasively monitors blood pressure in arteries deep beneath the skin could help people detect cardiovascular problems earlier on and with greater precision. In tests, the patch performed as well as some clinical methods to measure blood pressure. Applications include real-time, continuous monitoring of blood pressure changes in patients with heart or lung disease, as well as patients who are critically ill or undergoing surgery.

Researchers Develop Biometric Tool for Newborn Fingerprinting

Researchers at the University of California San Diego say they have dramatically advanced the science of biometric identification, creating a novel technology that can capture the fingerprints of infants and children, even on the first day of birth.

A Single Gene Mutation May Have Helped Humans Become Optimal Long-Distance Runners

Two to three million years ago, the functional loss of a single gene triggered a series of changes in what would eventually become the modern human species. Researchers at University of California San Diego School of Medicine report on studies of mice engineered to lack the same gene and resulting data that suggest the lost gene may also have contributed to humanity’s well-documented claim to be among the best long-distance runners in the animal kingdom.

Zika Virus Strips Immune Cells of their Identity

Macrophages are immune cells that are supposed to protect the body from infection by viruses and bacteria. Yet Zika virus preferentially infects these cells. Researchers at University of California San Diego School of Medicine have now unraveled how the virus shuts down the genes that make macrophages function as immune cells.

Chronic Diseases Driven by Metabolic Dysfunction

Progress in treating chronic illness, where the cause of the problem is often unknown, has lagged. Chronic conditions like cancer, diabetes and cardiovascular disease defy easy explanation, let alone remedy. In a new paper, a researcher at University of California San Diego School of Medicine, posits that chronic disease is essentially the consequence of the natural healing cycle becoming blocked, specifically by disruptions at the metabolic and cellular levels.

Building a Better Brain-in-a-Dish, Faster and Cheaper

Writing in the current online issue of the journal Stem Cells and Development, researchers at University of California San Diego School of Medicine describe development of a rapid, cost-effective method to create human cortical organoids directly from primary cells.

UC San Diego and Deerfield Management Create Poseidon Innovation to Advance Disease-Curing Therapeutics

University of California San Diego and Deerfield Management announce today the creation of Poseidon Innovation, LLC to advance disease-curing therapeutics. Through Deerfield’s $65-million commitment in Poseidon, UC San Diego investigators will have the funding and support to weather risky early-stage processes and expedite the drug-development cycle, allowing patients to receive treatment faster.

New National Training Program Aims to Mainstream Glycosciences

Over the next five years, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, will award approximately $20 million to four academic centers to launch a new national Career Development Consortium for Excellence in Glycosciences.

Researcher Links Diplomats’ Mystery Illness to Radiofrequency/Microwave Radiation

Writing in advance of the September 15 issue of Neural Computation, Beatrice Golomb, MD, PhD, professor of medicine at University of California San Diego School of Medicine, says publicly reported symptoms and experiences of a “mystery illness” afflicting American and Canadian diplomats in Cuba and China strongly match known effects of pulsed radiofrequency/microwave electromagnetic (RF/MW) radiation.

Researchers to Test Novel Drug Combination Against Toughest Breast Cancers

Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.